StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research report report published on Tuesday. The brokerage issued a hold rating on the stock.
Separately, Benchmark reissued a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a research note on Wednesday, November 20th.
View Our Latest Report on Milestone Scientific
Milestone Scientific Price Performance
Hedge Funds Weigh In On Milestone Scientific
Hedge funds have recently added to or reduced their stakes in the stock. Y Intercept Hong Kong Ltd acquired a new position in shares of Milestone Scientific during the 3rd quarter worth about $48,000. World Investment Advisors LLC bought a new position in Milestone Scientific during the 3rd quarter worth approximately $91,000. Carnegie Investment Counsel grew its holdings in Milestone Scientific by 18.9% during the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after purchasing an additional 27,412 shares during the period. Finally, Geode Capital Management LLC increased its stake in Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after purchasing an additional 31,572 shares in the last quarter. Institutional investors and hedge funds own 5.79% of the company’s stock.
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Recommended Stories
- Five stocks we like better than Milestone Scientific
- What is the NASDAQ Stock Exchange?
- SAP’s Strong Momentum: A Bullish Setup for Investors
- EV Stocks and How to Profit from Them
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- What is the Nikkei 225 index?
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.